AOD-9604
Extensively Studied
AOD-9604 is a modified 17-amino acid fragment of human growth hormone (hGH 176-191) with an added N-terminal tyrosine. It stimulates fat burning and blocks new fat storage without the growth-promoting effects of full hGH. Unlike intact growth hormone, AOD-9604 does not increase IGF-1, affect glucose metabolism, or bind to the GH receptor.
How it works
AOD-9604 stimulates fat burning and blocks new fat storage by activating fat-burning receptors, without binding to the GH receptor. This selective action provides fat loss effects without the high blood sugar, insulin resistance, or unwanted cell growth associated with full growth hormone.
Key benefits
- ✓Stimulates fat burning and blocks new fat storage without growth hormone side effects
- ✓Does not increase IGF-1 or affect glucose metabolism
- ✓Shows promise for cartilage repair and joint health
- ✓Well-studied safety profile with no impact on insulin or blood sugar
Related goals
Protocols
| Protocol | Dose | Frequency |
|---|---|---|
| Fat loss | 250-300mcg | Once daily |
| Enhanced fat loss | 400-500mcg | Once daily |
| Joint support | 250mcg | Once daily |
| Conservative start | 200mcg | Once daily |
Protocols are from published research literature. This is not medical advice. Dosing should be determined by a licensed clinician.
What to expect
Minimal noticeable effects, compound building in system
May notice subtle changes in body composition
More noticeable fat loss, especially with diet and exercise
Continued fat reduction, improved body composition
What to know
- ⚠Generally well-tolerated in clinical trials
- ⚠Does not affect blood glucose or insulin - safer than full hGH
- ⚠Does not increase IGF-1 levels
- ⚠May cause mild injection site reactions
- ⚠Not recommended during pregnancy or breastfeeding
- ⚠WADA prohibited substance - not for competitive athletes